169320 ⎘
Investigating or analysing materials by specific methods not covered by groups -; Biological material, e.g. blood, urine ; Haemocytometers; Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids; Immunoglobulins Anti-idiotype
BORRELIA BURGDORFERI PEPTIDOGLYCAN AS A DIAGNOSTIC AND TARGET FOR THERAPEUTIC INTERVENTION OF LYME DISEASE-RELATED PATHOLOGIES
#2USE OF CEREBROSPINAL FLUID-DERIVED ANTI-VIMENTIN IGG AS MARKER IN DIAGNOSIS OF VIMENTIN ANTIBODY-ASSOCIATED ASTROCYTOPATHY
#3ANTI-DRUG ANTIBODY ASSAY
#4ANTIGEN BINDING MOLECULES AND METHODS OF USE THEREOF
#5METHODS FOR TREATING PROGRESSIVE MULTIPLE SCLEROSIS
#6GENERATION OF HUMAN ALLERGEN- AND HELMINTH-SPECIFIC IGE MONOCLONAL ANTIBODIES FOR DIAGNOSTIC AND THERAPEUTIC USE
#7Methods for Detecting Antibody Self-Association
#8Detection of B Cell Antibody Responses in Patients with Haemophilia and Treatment Thereof
#9METHODS AND PRODUCTS FOR EVALUATING AN IMMUNE RESPONSE TO A THERAPEUTIC PROTEIN
#10HOMEOBOX TRANSCRIPTION FACTOR VENTX REGULATES DIFFERENTIATION AND MATURATION OF HUMAN DENDRITIC CELLS
#11GENERATION OF HUMAN ALLERGEN- AND HELMINTH-SPECIFIC IGE MONOCLONAL ANTIBODIES FOR DIAGNOSTIC AND THERAPEUTIC USE
#12ARTIFICIAL TARGET FOR ANTIGEN-SPECIFIC ACTIVATION AND EXPANSION OF CAR T CELLS
#13METHODS OF QUANTIFYING ANTI-CD40 ANTIBODIES
#14Food-allergen specific antibody compositions
#15METHODS FOR TREATING PROGRESSIVE MULTIPLE SCLEROSIS
#16METHODS FOR THE DETECTION OF ANTI-DRUG ANTIBODIES AGAINST FACTOR XI AND/OR FACTOR XIA ANTIBODIES
#17COMPLEX-SPECIFIC ANTIBODIES AND ANTIBODY FRAGMENTS AND ITS USE
#18ALLERGEN-IMMOBILIZED CARRIER AND METHOD OF DETECTING ALLERGEN-SPECIFIC ANTIBODY
#19ANTI-MICROBIAL ANTIBODY SIGNATURES OF INFLAMMATORY BOWEL DISEASE AND USES THEREOF
#20ASSAYS AND METHODS FOR THE DIAGNOSIS OF POST-STREPTOCOCCAL DISORDERS
#21ANTI-IDIOTYPIC ANTIBODIES AGAINST ANTI-CD19 ANTIBODIES
#22METHODS FOR MITIGATING INTERFERENCE BY THERAPEUTIC ANTI-CD47 ANTIBODIES IN PRE-TRANSFUSION ASSAYS
#23METHODS AND MATERIALS FOR IDENTIFYING AND TREATING MEMBRANOUS NEPHROPATHY
#24Methods and reagents for determining immunoglobulin gamma (IgG) antibody isotype concentration from biological samples
#25Multiplex Isotype-Specific Antibody Detection
#26ANTI-IDIOTYPIC ANTIBODIES TO ROR1-TARGETED BINDING DOMAINS AND RELATED COMPOSITIONS AND METHODS
#27Antibody selection method
#28COMPOSITIONS AND METHODS FOR DIAGNOSING NARCOLEPSY
#29ANTI-DRUG ANTIBODY ASSAY
#30ANTI-IDIOTYPIC ANTIBODIES AGAINST ANTI-CD79B ANTIBODIES
#31Antigen binding molecules specific for an anti-CD19 scFV
#32METHODS FOR TREATING PROGRESSIVE MULTIPLE SCLEROSIS
#33Generation of human allergen- and helminth-specific IgE monoclonal antibodies for diagnostic and therapeutic use
#34DIAGNOSIS OF CANCER USING DETECTION OF ANTIBODIES DIRECTED AGAINST PD1 AND PD-L1
#35MOUSE MONOCLONAL ANTIBODIES AGAINST GALACTOSE-DEFICIENT IGA1,PREPARATION METHOD THEREOF, AND USE THEREOF
#36INTERFERENCE-SUPPRESSED PHARMACOKINETIC IMMUNOASSAY
#37Generation of human allergen- and helminth-specific IgE monoclonal antibodies for diagnostic and therapeutic use
#38Rabbit antibodies to human immunoglobulins G
#39BORRELIA BURGDORFERI PEPTIDOGLYCAN AS A DIAGNOSTIC AND TARGET FOR THERAPEUTIC INTERVENTION OF LYME DISEASE-RELATED PATHOLOGIES
#40SUBSTANCES, VACCINES AND METHODS FOR DIAGNOSING AND REDUCING INCIDENCES OF TRANSPLANT REJECTION
#41ANTI-IDIOTYPE ANTIBODIES AND METHODS OF USING THE SAME
#42Composition for diagnosing allergies to mites, method of diagnosing allergies to mites, and composition for preventing or treating allergies to mites
#43METHODS FOR TREATING PROGRESSIVE MULTIPLE SCLEROSIS
#44Methods of detecting donor-specific antibodies and systems for practicing the same
#45Nanoallergens and uses thereof
#46Paired microparticles-based kits for detecting analytes
#47Antibodies to carcinoembryonic antigen-related cell adhesion molecule (CEACAM)
#48Methods and products for evaluating an immune response to a therapeutic protein
#49METHODS OF QUALITATIVELY AND/OR QUANTITATIVELY ANALYZING PROPERTIES OF ACTIVATABLE ANTIBODIES AND USES THEREOF
#50LATERAL FLOW IMMUNOASSAYS FOR THE DETECTION OF ANTIBODIES AGAINST BIOLOGICAL DRUGS
#51USE OF ANTI-CD26 ANTIBODY LEVELS AS AUTOIMMUNE AND/OR INFLAMMATORY DISEASE BIOMARKERS
#52Antigen binding molecules specific for an anti-CD19 scFv
#53COMPLEX-SPECIFIC ANTIBODIES AND ANTIBODY FRAGMENTS AND ITS USE
#54Human Monoclonal Antibodies Against CD20
#55Multiplex isotype-specific antibody detection
#56Method of removing non-specific binding signals using microparticle assay
#57Kit for detecting coronary artery disease comprising an MAA protein adduct and reagents that bind to antibodies
#58HOMEOBOX TRANSCRIPTION FACTOR VENTX REGULATES DIFFERENTIATION AND MATURATION OF HUMAN DENDRITIC CELLS
#59Antibody selection method
#60METHODS FOR TREATING PROGRESSIVE MULTIPLE SCLEROSIS
#61Generation of human allergen- and helminth-specific IgE monoclonal antibodies for diagnostic and therapeutic use
#62Idiotypic antibodies against anti-PD-L1 antibodies and uses thereof
#63Drug containing carrier into cell for forming immune complex
#64MULTIPLEX MEASURE OF ISOTYPE ANTIGEN RESPONSE
#65ANTI-DRUG ANTIBODY ASSAY
#66DIAGNOSTIC METHOD FOR PEDIATRIC ACUTE-ONSET NEUROPSYCHIATRIC SYNDROME (PANS) AND PEDIATRIC AUTOIMMUNE NEUROPSYCHIATRIC DISORDER ASSOCIATED WITH STREPTOCOCCI INFECTION (PANDAS)
#67METHODS FOR TREATING PROGRESSIVE MULTIPLE SCLEROSIS
#68Methods of detecting donor-specific antibodies and systems for practicing the same
#69Nanoallergens and uses thereof
#70Methods and reagents for determining immunoglobulin gamma (IgG) antibody isotype concentration from biological samples
#71Complex-specific antibodies and antibody fragments and its use
#72Methods and products for evaluating an immune response to a therapeutic protein
#73Antigen binding molecules specific for an anti-CD19 scFv
#74Methods for diagnosing and reducing incidences of cardiac allograft rejection
#75Diagnostic method for pediatric acute-onset neuropsychiatric syndrome (PANS) and pediatric autoimmune neuropsychiatric disorder associated with streptococci infection (PANDAS)
#76Methods of identifying bacteria comprising binding polypeptides
#77ANTIBODIES COMPRISING SEQUENCES FROM CAMELIDAE TO HIGHLY CONSERVED TARGETS
#78Prognostic Marker For Cryoglobulinemic Vasculitis And B Cell Malignancies In HCV Infected Patients
#79SPECIFIC DETECTION OF RAT ANTIBODIES IN MOUSE SERUM
#80ANTIBODIES TO CARCINOEMBRYONIC ANTIGEN-RELATED CELL ADHESION MOLECULE (CEACAM)
#81Methods for treating progressive multiple sclerosis
#82Lateral flow immunoassays for the detection of antibodies against biological drugs
#83Anti-pembrolizumab antibodies
#84Anti-CD154 antibodies and methods of using them
#85Methods for treating progressive multiple sclerosis
#86Cell lines expressing surface bound anti-idiotype antibodies against anti-CD22 antibodies and uses thereof
#87Specific Detection of Rat Antibodies in Mouse Serum
#88Method of determining resistance to influenza virus
#89Monoclonal antibodies capable of reacting with a plurality of influenza virus A subtypes
#90Diagnostic method for pediatric acute-onset neuropsychiatric syndrome (PANS) and pediatric autoimmune neuropsychiatric disorder associated with streptococci infection (PANDAS)
#91Single domain antibodies directed against STAT3
#92Single domain antibodies directed against KRAS
#93Single domain antibodies directed against TNF-alpha
#94Specific detection of rat antibodies in mouse serum
#95Monoclonal antibodies capable of reacting with a plurality of influenza virus A subtypes
#96Methods of detecting donor-specific antibodies and systems for practicing the same
#97IDIOTYPIC ANTIBODIES AND USES THEREOF
#98Anti-human IgG1 antibody
#99METHODS FOR TREATING PROGRESSIVE MULTIPLE SCLEROSIS
#100NON-B-LINEAGE CELLS CAPABLE OF PRODUCING ANTIBODY
#101Serological markers of inflammatory bowel disease phenotype and disease progression
#102Methods for detecting antibodies
#103Anthrose-based compositions and related methods
#104Methods for producing high-fidelity autologous idiotype vaccines
#105Human autoantibodies specific for PAD3 which are cross-reactive with PAD4 and their use in the diagnosis and treatment of rheumatoid arthritis and related diseases
#106Method for the detection of a multispecific binder
#107Complex-specific antibodies and antibody fragments and its use
#108Combination hepatitis C virus antigen and antibody detection method
#109Anti-CD22 anti-idiotypic antibodies and uses thereof
#110Compositions and methods comprising binding proteins for adalimumab
#111Multiplexed chromatography-immunoassay method for the characterization of circulating immune complexes
#112SOLID SUPPORT AND METHOD FOR DETECTING AN ANALYTE IN A SAMPLE
#113Methods and products for evaluating an immune response to a therapeutic protein
#114DRUG CONTAINING CARRIER INTO CELL FOR FORMING IMMUNE COMPLEX
#115Anti-idiotype antibody against anti-c-MET antibody
#116Antibodies to carcinoembryonic antigen-related cell adhesion molecule (CEACAM)
#117Method of predicting responsiveness of B cell lineage malignancies to active immunotherapy
#118IP-10 antibody dosage escalation regimens
#119Human Monoclonal Antibodies Against CD20
#120IP-10 ANTIBODY DOSAGE ESCALATION REGIMENS
#121COMPOSITIONS AND METHOD FOR TREATING AUTOIMMUNE DISEASES
#122METHODS FOR DIAGNOSING IRRITABLE BOWEL SYNDROME
#123ANTI-HUMAN IgG1 ANTIBODY
#124Anti-idiotype antibody against an antibody against the amyloid β peptide
#125Idiotypic antibodies and uses thereof
#126Molecules mimicking an autoantibody idiotype and compositions containing same
#127Prognostic marker for cryoglobulinemic vasculitis and B cell malignancies in HCV infected patients
#128METHODS FOR TREATING PROGRESSIVE MULTIPLE SCLEROSIS
#129METHODS OF ASSESSING CROHN'S DISEASE PATIENT PHENOTYPE BY I2, OMPC AND ASCA SEROLOGIC RESPONSE
#130Methods and products for evaluating an immune response to a therapeutic protein
#131DIAGNOSTIC DEVICE AND METHOD
#132Assays for detecting antibodies specific to therapeutic anti-IgE antibodies and their use in anaphylaxis
#133Monoclonal antibodies capable of reacting with a plurality of influenza virus A subtypes
#134DIAGNOSTIC DEVICE AND METHOD
#135Ganglioside associated recombinant antibodies and the use thereof in the treatment of tumors
#136SEROLOGICAL MARKERS OF INFLAMMATORY BOWEL DISEASE PHENOTYPE AND DISEASE PROGRESSION
#137Methods of assessing Crohn's disease patient phenotype by I2 serologic response
#138Citrullinated fibrin-filaggrin chimeric polypeptide capable of detecting the antibodies generated in rheumatoid arthritis
#139Multi-stage nutrigenomic diagnostic food sensitivity testing in animals
#140Anti-ganglioside antibodies and compositions
#141Anti-idiotype antibody against an antibody against the amyloid β peptide
#142Method for Diagnosis and Treatment of Pancreatic Cancer
#143METHODS FOR TREATING PROGRESSIVE MULTIPLE SCLEROSIS
#144Methods and Compositions Comprising Anti-Idiotypic Antibodies to Anti-MMP-14 Antibodies
#145Methods and products for evaluating an immune response to a therapeutic protein
#146Compositions and methods comprising binding proteins for adalimumab
#147ANTI-DRUG ANTIBODY ASSAY
#148Sensing Device and Method For Determination of Teh Amount of Target Molecule in an Analyte
#149Methods for Determining the Bivalency of Protein and Antibody Therapeutics
#150ASSAY FOR DIABETES
#151Assay for Antibodies
#152Methods for diagnosing irritable bowel syndrome
#153Method for identifying a ligand capable of selectively modulating a functional cascade involving a target, and uses thereof for high-throughput screening of molecules of interest
#154Conjugate and its use as a standard in an immunoassay
#155Combination hepatitis C virus antigen and antibody detection method
#156Computational systems for biomedical data
#157METHODS FOR DIAGNOSING IRRITABLE BOWEL SYNDROME
#158Computational systems for biomedical data
#159Computational systems for biomedical data
#160Diagnosis and treatment for immunoglobulin E (IgE) implicated disorders
#161Polynucleotides encoding anti-ganglioside antibodies
#162Assay for diabetes
#163Assay for Antibodies
#164Method for identifying and designing immunogenic peptides
#165Method for the detection of stress biomarkers including cortisol by fluorescence polarization
#166Assay for antibodies
#167Method for obtaining anti-idiotype antibodies
#168Murine monoclonal anti-idiotype antibody 11D10 and methods of use thereof
#169Immunotherapeutic combinations for the treatment of tumours that overexpress gangliosides
#170Methods of assessing Crohn's disease patient phenotype by I2, OmpC and ASCA serologic response
#171Diagnostic for scleroderma